跳至主要内容
临床试验/DRKS00024509
DRKS00024509已完成不适用

High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. - HPR TEG-AF PCI

Kardiologie und Angiologie0 个研究点目标入组 172 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • - Informed consent
  • - Age of =18
  • - Atrial fibrillation/flutter with an indication for permanent anticoagulation therapy (i.e. CHA2DS2VASC =1 for man and CHA2DS2VASC =2 for women)
  • - Percutaneous coronary intervention in the previous 3 days

排除标准

  • - Contraindication for Clopidogrel intake
  • - History of stent-thrombosis
  • - Patient not suitable for inclusion in the study
  • (e.g. incompliance, drug abuse, unwillingness to adhere to the protocol)
  • - GPIIb/IIIa inhibition within the last 24h
  • - Use of Prasugrel or Ticagrelor within the last 7 days
  • - Less than 50 thousand platelets per µl blood

研究者

发起方
Kardiologie und Angiologie

相似试验